FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer

 
Share
 

Manage episode 200758339 series 1452688
By ReachMD. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.

FDA medical oncologists discuss the approval of osimertinib for EGFR mutation-positive non-small cell lung cancer.

Released July 28, 2017

153 episodes